M
Meryl S. LeBoff
Researcher at Brigham and Women's Hospital
Publications - 197
Citations - 19056
Meryl S. LeBoff is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Osteoporosis & Bone density. The author has an hindex of 59, co-authored 179 publications receiving 16933 citations. Previous affiliations of Meryl S. LeBoff include Harvard University & University of Manitoba.
Papers
More filters
Journal ArticleDOI
Clinician’s Guide to Prevention and Treatment of Osteoporosis
Felicia Cosman,S. J. de Beur,Meryl S. LeBoff,E. M. Lewiecki,B. Tanner,S. Randall,Robert Lindsay +6 more
TL;DR: The Clinician’s Guide to Prevention and Treatment of Osteoporosis was developed by an expert committee of the National Osteiporosis Foundation in collaboration with a multispecialty council of medical experts in the field of bone health convened by NOF.
Journal ArticleDOI
Comparison of Weight-Loss Diets with Different Compositions of Fat, Protein, and Carbohydrates
Frank M. Sacks,George A. Bray,Vincent J. Carey,Steven R. Smith,Donna H. Ryan,Stephen D. Anton,Katherine McManus,Catherine M. Champagne,Louise M. Bishop,Nancy Laranjo,Meryl S. LeBoff,Jennifer Rood,Lilian de Jonge,Frank L. Greenway,Catherine M. Loria,Eva Obarzanek,Donald A. Williamson +16 more
TL;DR: Low-calorie diets result in clinically meaningful weight loss regardless of which macronutrients they emphasize, and improved lipid-related risk factors and fasting insulin levels.
Journal ArticleDOI
Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.
Jane A. Cauley,John A Robbins,Zhao Chen,Steven R. Cummings,Rebecca D. Jackson,Andrea Z. LaCroix,Meryl S. LeBoff,Cora E. Lewis,Joan McGowan,Joan M. Neuner,Mary Pettinger,Marcia L. Stefanick,Jean Wactawski-Wende,Nelson B. Watts +13 more
TL;DR: It is demonstrated that estrogen plus progestin increases BMD and reduces the risk of fracture in healthy postmenopausal women and there was no net benefit when considering the effects of hormone therapy on other important disease outcomes in a global model.
Journal ArticleDOI
A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study
Charles H. Chesnut,Stuart L. Silverman,Kim Andriano,Harry K. Genant,Alberto Gimona,Steven T. Harris,Douglas P. Kiel,Meryl S. LeBoff,Michael Maricic,Paul D. Miller,Caje Moniz,Munro Peacock,P J Richardson,Nelson B. Watts,David J. Baylink +14 more
TL;DR: A 5-year, double-blind, randomized, placebo-controlled study was conducted to determine whether salmon calcitonin nasal spray reduced the risk of new vertebral fractures in postmenopausal women with osteoporosis.
Journal ArticleDOI
Age‐related intrinsic changes in human bone‐marrow‐derived mesenchymal stem cells and their differentiation to osteoblasts
Shuanhu Zhou,Joel S. Greenberger,Michael W. Epperly,Julie P. Goff,Carolyn Adler,Meryl S. LeBoff,Julie Glowacki +6 more
TL;DR: There is an age‐dependent decrease in proliferation and osteoblast differentiation, and an increase in senescence‐associated β‐galactosidase‐positive cells and apoptosis in hMSCs, which supports the view that there are intrinsic alterations in human MSCs with aging that may contribute to the process of skeletal aging in humans.